The Community Guide

- gsearch

Search Results

Narrow Results:

2024 7
2021 3

United States 9

1 - 10 of 10 Results

Refine Results

Refine Results:

Supplementary Figure 2. Coverage With ≥1 Dose of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (a), ≥1 Dose of Quadrivalent Meningococcal Conjugate Vaccine (B), ≥1 Dose of Human Papillomavirus Vaccine (C) and Percentage of Adolescents Up to Date With Human Papillomavirus Vaccination (D), Among Adolescents Born During 2007–2010, — National Immunization Survey-Teen, United States, 2015–2023

CITE Title : Supplementary Figure 2. Coverage With ≥1 Dose of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (a), ≥1 Dose of Quadrivalent Meningococcal Conjugate Vaccine (B), ≥1 Dose of Human Papillomavirus Vaccine (C) and Percentage of Adolescents Up to Date With Human Papillomavirus Vaccination (D), Among Adolescents Born During 2007–2010, — National Immunization Survey-Teen, United States, 2015–2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 08/22/2024 Pages in Document : 3 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 33 URL : https://stacks.cdc.gov/view/cdc/159389 Centers for Disease Control and Prevention (U.S.) (2024). Supplementary Figure 2. Coverage With ≥1 Dose of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (a), ≥1 Dose of Quadrivalent Meningococcal Conjugate Vaccine (B), ≥1 Dose of Human Papillomavirus Vaccine (C) and Percentage of Adolescents Up to Date With Human Papillomavirus Vaccination (D), Among Adolescents Born During 2007–2010, — National Immunization Survey-Teen, United States, 2015–2023. 73(33). Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 2. Coverage With ≥1 Dose of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (a), ≥1 Dose of Quadrivalent Meningococcal Conjugate Vaccine (B), ≥1 Dose of Human Papillomavirus Vaccine (C) and Percentage of Adolescents Up to Date With Human Papillomavirus Vaccination (D), Among Adolescents Born During 2007–2010, — National Immunization Survey-Teen, United States, 2015–2023" 73, no. 33 (2024) Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 2. Coverage With ≥1 Dose of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (a), ≥1 Dose of Quadrivalent Meningococcal Conjugate Vaccine (B), ≥1 Dose of Human Papillomavirus Vaccine (C) and Percentage of Adolescents Up to Date With Human Papillomavirus Vaccination (D), Among Adolescents Born During 2007–2010, — National Immunization Survey-Teen, United States, 2015–2023" vol. 73, no. 33, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

08/22/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR-2024-73-33
Supplementary Figure 1. Estimated Vaccination Coverage With Selected Vaccines and Doses Among Adolescents Aged 13–17 Years, by Survey Year — National Immunization Survey-Teen, United States, 2006–2023

CITE Title : Supplementary Figure 1. Estimated Vaccination Coverage With Selected Vaccines and Doses Among Adolescents Aged 13–17 Years, by Survey Year — National Immunization Survey-Teen, United States, 2006–2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 08/22/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 33 URL : https://stacks.cdc.gov/view/cdc/159388 Centers for Disease Control and Prevention (U.S.) (2024). Supplementary Figure 1. Estimated Vaccination Coverage With Selected Vaccines and Doses Among Adolescents Aged 13–17 Years, by Survey Year — National Immunization Survey-Teen, United States, 2006–2023. 73(33). Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 1. Estimated Vaccination Coverage With Selected Vaccines and Doses Among Adolescents Aged 13–17 Years, by Survey Year — National Immunization Survey-Teen, United States, 2006–2023" 73, no. 33 (2024) Centers for Disease Control and Prevention (U.S.) "Supplementary Figure 1. Estimated Vaccination Coverage With Selected Vaccines and Doses Among Adolescents Aged 13–17 Years, by Survey Year — National Immunization Survey-Teen, United States, 2006–2023" vol. 73, no. 33, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

08/22/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR-2024-73-33
Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season

CITE Title : Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/31/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 43 URL : https://stacks.cdc.gov/view/cdc/166705 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season. 73(43). Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season" 73, no. 43 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season" vol. 73, no. 43, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/31/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 43, October 31, 2024
Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024

CITE Title : Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162445 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024

CITE Title : Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162444 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024

CITE Title : Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162443 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures]

CITE Title : COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures] Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/03/2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 39 URL : https://stacks.cdc.gov/view/cdc/162446 Centers for Disease Control and Prevention (U.S.). (2024). COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures]. 73(39). Centers for Disease Control and Prevention (U.S.). "COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures]" 73, no. 39 (2024) Centers for Disease Control and Prevention (U.S.). "COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures]" vol. 73, no. 39, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/03/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure 1. Percentage of COVID-19–Associated Hospitalizations Among Adults Aged ≥18 Years, by Week and Age Group — COVID-NET, 12 St...
COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-02]

CITE Title : COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-02] Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : February 2021 Pages in Document : 85 numbered pages Series : Vaccinate with Confidence URL : https://stacks.cdc.gov/view/cdc/104372 Centers for Disease Control and Prevention (U.S.) (2021). COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-02]. Centers for Disease Control and Prevention (U.S.) "COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-02]" (2021) Centers for Disease Control and Prevention (U.S.) "COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-02]" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

February 2021 | Vaccinate with Confidence

:

This rapid community assessment guide is for staff of state and local health departments involved in various aspects of COVID-19 vaccine planning who ...
COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-10]

CITE Title : COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-10] Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : October 2021 Pages in Document : 87 numbered pages Series : Vaccinate with Confidence URL : https://stacks.cdc.gov/view/cdc/113701 Centers for Disease Control and Prevention (U.S.) (2021). COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-10]. Centers for Disease Control and Prevention (U.S.) "COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-10]" (2021) Centers for Disease Control and Prevention (U.S.) "COVID-19 Vaccine Confidence Rapid Community Assessment Guide [2021-10]" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

October 2021 | Vaccinate with Confidence

:

This rapid community assessment (RCA) guide is for staff of state, territorial, local, and tribal health departments involved in various aspects of CO...
Si he resultado positivo para COVID-19, ¿todavía necesito la vacuna?

CITE Title : Si he resultado positivo para COVID-19, ¿todavía necesito la vacuna? Corporate Authors(s) : CPWR--The Center for Construction Research and Training;National Institute for Occupational Safety and Health; Published Date : 12/01/2021 Pages in Document : 1 pdf page URL : https://stacks.cdc.gov/view/cdc/116123 CPWR--The Center for Construction Research and Training (2021). Si he resultado positivo para COVID-19, ¿todavía necesito la vacuna?. CPWR--The Center for Construction Research and Training "Si he resultado positivo para COVID-19, ¿todavía necesito la vacuna?" (2021) CPWR--The Center for Construction Research and Training "Si he resultado positivo para COVID-19, ¿todavía necesito la vacuna?" , 2021 Export RIS Citation Information.

:

CPWR--The Center for Construction Research and Training ...

12/01/2021 | National Institute for Occupational Safety and Health (NIOSH)

:

Esta infografía proporciona información sobre qué hacer si pruebas positivo para COVID-19 y deseas vacunarte.